What a brutal six months it’s been for 10x Genomics. The stock has dropped 52.1% and now trades at $10.59, rattling many ...

Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating restated by equities researchers at Weiss Ratings in a note issued to investors on Friday,Weiss Ratings reports. A number of ...

Genomics (NASDAQ:TXG – Get Free Report) had its price target reduced by investment analysts at Citigroup from $20.00 to $15.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage ...

Viewers can become desensitised to legal adult pornography and seek out more extreme material, a charity said.

Citi lowered the firm’s price target on 10x Genomics (TXG) to $15 from $20 and keeps a Buy rating on the shares. The firm updated models in the ...

Genomics announced that its ATAC-Seq patents were found valid and infringed in its patent litigation with Parse Biosciences.

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived ...

MediaTek's latest chipsets continue the trend of marginal overhauls over their predecessors. The brand-new Dimensity 7400 and 7400X are near carbon copies of last year’s Dimensity 7300 and 7300X ...

Detailed price information for Torex Gold Resources Inc (TORXF) from The Globe and Mail including charting and trades.

Genomics, Inc. , a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference ...

Building on a record year of Chromium product releases in 2024, 10x Genomics announced plans to enable high-performance, mega ...